跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
探討Dicer在胰臟癌細胞對gemcitabine感受性的影響及其調控機制(2/3)
Su, Yen-Hao
(PI)
外科學科
研究計畫
:
A - 政府部門
›
b - 國家科學及技術委員會
概覽
指紋
指紋
探索此專案觸及的研究主題。這些標籤是根據基礎獎勵/補助款而產生。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine and Dentistry
Gemcitabine
100%
Pancreas Cancer
100%
Dicer
100%
microRNA
21%
Pancreatic Ductal Adenocarcinoma
15%
Clinical Significance
5%
Tumor Cell
5%
Gene Linkage
5%
Drug
5%
Cell Marker
5%
Drug Response
5%
Protein Processing
5%
Cancer Cell
5%
Maturation
5%
Pathophysiology
5%
Side Population
5%
Pancreatic Cancer Cell Line
5%
Biological Functions
5%
Cancer Types
5%
Cancer
5%
Cancer Stem Cell
5%
Therapeutic Agent
5%
Diagnosis
5%
Clinical Trial
5%
Tumor Progression
5%
Ribonuclease
5%
Stem Cell
5%
Pharmacology, Toxicology and Pharmaceutical Science
Pancreas Cancer
100%
Dicer
100%
Gemcitabine
100%
microRNA
21%
Malignant Neoplasm
10%
Tumor Growth
5%
Drug
5%
Cell Marker
5%
Ribonuclease
5%
Clinical Trial
5%
Neoplasm
5%
Pathophysiology
5%
Biochemistry, Genetics and Molecular Biology
Gemcitabine
100%
Dicer
100%
MicroRNA
15%
Animal Model
10%
Cancer Cell
10%
Maturation
5%
CD44
5%
Stem Cell Marker
5%
Ribonuclease
5%
Biological Functions
5%
Clinical Trial
5%
Tumor Progression
5%
Gene Linkage
5%
Posttranslational Modification
5%
Drug Response
5%
CD24
5%
Anabolism
5%
Side Population
5%
Endoribonuclease
5%
Cancer Stem Cell
5%